Fast and efficient three-step target-specific curing of a virulence plasmid in Salmonella enterica
© de Moraes and Teplitski. 2015
Received: 1 July 2015
Accepted: 30 July 2015
Published: 14 August 2015
Virulence plasmids borne by serovars of Salmonella enterica carry genes involved in its pathogenicity, as well as other functions. Characterization of phenotypes associated with virulence plasmids requires a system for efficiently curing strains of their virulence plasmids. Here, we developed a 3-step protocol for targeted curing of virulence plasmids. The protocol involves insertion of an I-SecI restriction site linked to an antibiotic resistance gene into the target plasmid using λ-Red mutagenesis, followed by the transformation with a temperature-sensitive auxiliary plasmid which carries I-SecI nuclease expressed from a tetracycline-inducible promoter. Finally, the auxiliary plasmid is removed by incubation at 42 °C and the plasmid-less strains are verified on antibiotic-containing media. This method is fast and very efficient: over 90 % of recovered colonies lacked their virulence plasmid.
In many pathogens, including Salmonella enterica, virulence determinants are often carried on plasmids (rev. Etcheverria and Padola 2013; Fabrega and Vila 2013). Virulence plasmids are found in Salmonella enterica serovars Abortusovis, Choleraesuis, Dublin, Enteritidis, Gallinarum/Pullorum, Paratyphi C, Sendai, and Typhimurium (Akiba et al. 1999; Barrow and Lovell 1988; Barrow et al. 1987; Danbara et al. 1992; Gulig and Curtiss 1987; Libby et al. 1997; Liu et al. 2009; Nakamura et al. 1985; Ou et al. 1990), all of which are of medical or veterinary concern. These plasmids function as virulence determinants, contributing to pathogenesis of S. enterica, especially during the systemic phase of the disease (Libby et al. 1997; Uzzau et al. 2000). Virulence plasmids vary in size, ranging from 50 kb (sv. Choleraesuis) to 285 kb (sv. Sendai) (Feng et al. 2012). Despite overall differences in composition, some genetic components are conserved, most notably the virulence determinant spv operon which is expressed during infection and codes for SpvB, a toxin that ADP-ribosylates actin of the macrophage cell destabilizing its cytoskeleton (Heithoff et al. 1997; Lesnick et al. 2001; Tezcan-Merdol et al. 2001) and SpvC, a phosphothreonine lyase that helps subvert natural inflammation response to Salmonella enterica (Haneda et al. 2012; Mazurkiewicz et al. 2008). Intra-serovar diversity in plasmid composition has also been reported, although, on a more limited scale. For example, insertions led to the acquisition of antibiotic resistance genes in the virulence plasmid of the serovar Typhimurium, thus making it not only a virulence determinant, but also the source a multi-drug resistance phenotype (Herrero-Fresno et al. 2015).
Defining functions of virulence plasmids requires a process known as “plasmid curing”. Different methods were developed to cure bacteria of their virulence plasmids, they involve heat or chemical treatments to exclude the plasmid from the cell. Substances with DNA intercalating properties, gyrase inhibiting effects and selections against phenotypes associated with the plasmid were successfully employed in different bacterial species and plasmids [rev. (Trevors 1986)]. However, these methods have some important caveats: treatment with harsh chemicals that affect properties of DNA or functions of DNA replicating machine tend to select for mutants (although this effect has not been exhaustively explored). Counter-selection, using sensitivity to sucrose or fusaric acid (encoded by sacB or tetRA, respectively) can be fastidious and time-consuming, with low efficiency.
An alternative to methods based on chemical or temperature stresses is the curing by incompatibility. To this end, the host bacterium is transformed with a second plasmid from the same incompatibility group, this plasmid interferes with the replication of the native plasmid by competing for the replication and partitioning systems or interfering with the ability of the plasmid to correct fluctuations in its copy number (Novick 1987; Tinge and Curtiss 1990). To increase the potential of interfering with the resident plasmid, the secondary plasmid is usually smaller, high copy and carries an antibiotic marker to help the process with selective pressure. Despite the advantages, this system also requires the same counter-selective methods to remove the secondary plasmid from the host.
In this paper we describe a new system to cure the virulence plasmid of Salmonella enterica that is based on the λ-Red recombination and I-SecI meganuclease. This method differs from all other approaches because it is not based on exposure to stress or the use of incompatibility plasmids. It does not require fastidious counter-selection and works with high efficiency: over 90 % of the recovered colonies were cured of the virulence plasmid.
Materials and methods
Bacterial strains and culture conditions
Strains used in the study
S. enterica sv. Typhimurium ATCC 14028
S. enterica sv. Typhimurium MHM21
spvA::cat, I-SecI recognition site
S. enterica sv. Typhimurium MHM113
Lacks virulence plasmid p14028
cat, I-SecI recognition site
(Blank et al. 2011)
λ-Red genes under control of arabinose inducible promoter (P BAD ), I-SecI endonuclease under control of tetracycline inducible promoter (P tetA ), temperature sensitive, AmpR
(Blank et al. 2011)
I-SecI endonuclease under control of tetracycline inducible promoter (P tetA ), temperature sensitive, AmpR
The effect of different concentrations of anhydrotetracycline (AHT) on bacterial growth was analyzed by growth curves of S. enterica sv. Typhimurium MHM21 pMHM199. Overnight cultures were adjusted to OD600 = 0.01 in LB medium with 100 µg/ml ampicillin, and 200 µl of the culture were transferred to a well of a 96-wells plate with a range of AHT concentrations (0, 125, 500 and 1,000 ng/ml), with each condition assayed in triplicates. The plate was incubated in a plate reader (Victor3, Perkinelmer) at 30 °C and the absorbance at 590 nm was measured hourly.
Cloning and strains construction
Plasmid pMHM199 was constructed by amplifying I-SecI gene under the tetracycline inducible promoter P tetA , the regulator tetR, and the ampicillin resistance gene as well as the oriR101 origin of replication and temperature-sensitive repA101ts with primers CGAAATCCACTGAAAGCACA and AAGCTGCTTTTGAGCACCAC using pWRG99 (Blank et al. 2011) as a template and Q5® High-Fidelity DNA Polymerase (New England Labs). The resulting amplicon was treated with T4 DNA Ligase (New England Biolabs) under the conditions that favor intra-molecular ligation. The resulting plasmid was confirmed by the restriction digest. pMHM199 carries the endonuclease I-SecI under the promoter responsive to anhydrotetracycline P tetA .
The cassette containing the I-SecI site and chloramphenicol resistance gene was amplified from the template pWRG100 with primers (MHM91 ATGAATATGAATCAGACCACCAGTCCGGCACTTTCACAGGTCGAAACCGC CGCCTTACGCCCCGCCCTGC and MHM92 CTAAACTGCCGGCTGGCACGCAGAGTACCCGCAATCAACTGTTCCACCTG CTAGACTATATTACCCTGTT, where boldface letters indicate regions of homology with pWRG100 and italicized letters indicate homology with the spvA gene) using OneTaq® DNA polymerase. The resulting PCR fragment was inserted in the place of the spvA gene by λ-Red recombination (Datsenko and Wanner 2000). Briefly, electrocompetent cells were prepared using Salmonella enterica sv. Typhimurium 14028 harboring pKD46 grown in LB broth at 30 °C supplemented with 100 µg/ml ampicillin and 10 mM l-arabinose until OD600 = 0.6–0.8, for approximately 3–4 h.
The spvA PCR cassettes (10–50 ng) were electroporated into 50 µl aliquots of electrocompetents cells. Electroporations were carried out using MicroPulser (BioRad) using manufacturer’s instructions. Cells were recovered in SOB (Super Optimal Broth) containing 2 % w/v tryptone, 0.5 % w/v yeast extract, 10 mM NaCl, 10 mM MgCl2, 2.5 mM KCl (Sambrook and Russell 2001) and plated onto LB agar with 20 µg/ml chloramphenicol. The insertion was transduced into S. enterica sv. Typhimurium 14028 by phage P22. All insertions were confirmed by PCR (MHM29 CAGAATGGTCTGCTGCTCAC and MHM30 GGATTTCATTCTGTTTATTTTCAGG).
Efficiency of the plasmid curing system
Approximately 100 ng of purified pMHM199 were added to 50 µl of electrocompetent cells prepared from MHM21 strain. The cells were electroporated in 0.2 cm gap cuvettes with a MicroPulser (BioRad). Cells were resuspended in 1 ml of SOB medium and recovered for 1 h at 30 °C. The cells were divided in 350 µl aliquots and plated onto LB agar with 100 µg/ml ampicillin and supplemented with 0, 125 or 500 ng/ml AHT. The plates were incubated at 30 °C overnight. After the incubation, 50 colonies from each treatment were patched onto a new LB agar 100 µg/ml ampicillin plate and incubated at 30 °C overnight to purify the colonies and ensure that only bacteria carrying pMHM199 were present. The colonies were transferred to a new LB agar 20 µg/ml chloramphenicol plate and incubated at 37 °C overnight. The colonies that grew showing chloramphenicol resistance were defined as carrying pLST and the colonies that were chloramphenicol sensitive were defined as cured from pLST. To confirm the curing of pLST, the DNA from three chloramphenicol sensitive colonies and MHM21 as control were extracted using GenElute Bacterial DNA kit (Sigma-Aldrich) for a PCR targeting the plasmid genes repA (MHM1 GGCTATAGAGTGCGGTCTGG and MHM2 TCCGTGCAGTTTACGTTCAG, spvA (MHM29 and MHM30) and the chromosomal gene phoN (MHM7 TCATTTGCTGTGGCCAGTT and MHM8 TTATTGCCTGATCCGGAGTG) as a control.
The next step (Fig. 1c) consisted of the electroporation of MHM21 pSLT-cat with the helper plasmid pMHM199, which carries the I-SecI endonuclease gene under the tetracycline-activated promoter P tetA and tetR. The transformation reaction was directly plated onto LB agar containing ampicillin 100 μg/ml to maintain pMHM199 and AHT that induces the expression of I-SecI (via TetR). Then, the I-SecI endonuclease targets the I-SecI site on the 5′ end of the cat gene, which linearizes the virulence plasmid, leading to its loss in the subsequent generations.
The pMHM199 is a low copy, temperature-sensitive plasmid with replication origin based on pSC101, which allows easy curing by growing the cells in 42 °C for 6 h. The last step consists in the selection and confirmation of colonies cured of pSLT, by first selecting colonies that were chloramphenicol sensitive followed by PCR targeting the plasmid genes spvA and repA. The use of two targets at distant position on the plasmid helps to avoid the selection of mutants with segment deletions and integration to the chromosome. The resultant colonies were also confirmed to be ampicillin-sensitive, indicating loss of pMHM199.
Effect of AHT on cell growth
Plasmid curing efficiency
Plasmids carry functions important for interactions of pathogenic and symbiotic bacteria with their hosts. In S. enterica, virulence plasmids encode functions involved in virulence (such as spv), contributing to pathogenesis of S. enterica, especially during the systemic phase of the disease (Libby et al. 1997; Uzzau et al. 2000). Elucidation of the phenotypes associated with virulence plasmids required their efficient curing from the bacterial cells.
Various methods have been used to generate plasmid-less strains of S. enterica, however, most of them either have low efficiency or require that bacteria are cultured successively under the stressful conditions that likely result in the accumulation of second-site mutations. The method for curing virulence plasmids reported here is over 90 % efficient, which is significantly higher than 10−6–10−7 per generation reported for the same plasmid using novobiocin (Gulig and Curtiss 1987) or using the incompatibility plasmid and destabilization of the par locus (Tinge and Curtiss 1990). The latter method was 82 % efficient, however, 10 generations were required to achieve this level of efficiency (Tinge and Curtiss 1990).
The method described here could also be particularly useful in curing individual plasmids from strains that carry multiple plasmids. For example, multi-drug resistant strains of S. enterica currently circulating in Europe (Garcia et al. 2014) contain multiple plasmids, and the method described here could be used to efficiently remove individual plasmids. This method could also be used for the generation of vaccine strains, similar to the study of Matsui et al. (2015) who demonstrated that plasmid-cured S. enterica strains used as live vaccines have been tested as live vaccine strains providing nearly complete protection against virulent S. enterica in mice (Matsui et al. 2015).
We are grateful to Roman G. Gerlach for the generous gift of pWRG100 and pWRG99.
Compliance with ethical guidelines
Competing interests The authors declare that they have no competing interests.
Funding This research was supported by funding from the Center for Produce Safety and USDA NIFA-AFRI (Grant no. 2011-67017-30127).
Ethical approval All experiments with biological hazards were conducted in agreement with and following review by the University of Florida Office of Environmental Health. No animal or human subjects were involved in this research.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
- Akiba M, Sameshima T, Anzai T, Wada R, Nakazawa M (1999) Salmonella Abortusequi strains of equine origin harbor a 95 kb plasmid responsible for virulence in mice. Vet Microbiol 68(3–4):265–272View ArticlePubMedGoogle Scholar
- Barrow PA, Lovell MA (1988) The association between a large molecular mass plasmid and virulence in a strain of Salmonella Pullorum. J Gen Microbiol 134:2307–2316PubMedGoogle Scholar
- Barrow PA, Simpson JM, Lovell MA, Binns MM (1987) Contribution of Salmonella Gallinarum large plasmid toward virulence in fowl typhoid. Infect Immun 55(2):388–392PubMed CentralPubMedGoogle Scholar
- Blank K, Hensel M, Gerlach RG (2011) Rapid and highly efficient method for scarless mutagenesis within the Salmonella enterica chromosome. PLoS One 6(1):e15763. doi:10.1371/journal.pone.0015763 PubMed CentralView ArticlePubMedGoogle Scholar
- Danbara H, Moriguchi R, Suzuki S, Tamura Y, Kijima M, Oishi K et al (1992) Effect of 50 kilobase plasmid, pKDSC50, of Salmonella Choleraesuis Rf-1 strain on pig septicemia. J Vet Med Sci 54(6):1175–1178View ArticlePubMedGoogle Scholar
- Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97(12):6640–6645PubMed CentralView ArticlePubMedGoogle Scholar
- Etcheverria AI, Padola NL (2013) Shiga toxin-producing Escherichia coli: factors involved in virulence and cattle colonization. Virulence 4(5):366–372. doi:10.4161/viru.24642 PubMed CentralView ArticlePubMedGoogle Scholar
- Fabrega A, Vila J (2013) Salmonella enterica serovar Typhimurium skills to succeed in the host: virulence and regulation. Clin Microbiol Rev 26(2):308–341. doi:10.1128/CMR.00066-12 PubMed CentralView ArticlePubMedGoogle Scholar
- Feng Y, Liu J, Li YG, Cao FL, Johnston RN, Zhou J et al (2012) Inheritance of the Salmonella virulence plasmids: mostly vertical and rarely horizontal. Infect Gen Evol J Mol Epidem Evol Genet Infect Dis 12(5):1058–1063. doi:10.1016/j.meegid.2012.03.004 View ArticleGoogle Scholar
- Garcia P, Hopkins KL, Garcia V, Beutlich J, Mendoza MC, Threlfall J et al (2014) Diversity of plasmids encoding virulence and resistance functions in Salmonella enterica subsp. enterica serovar Typhimurium monophasic variant 4,,12: i:-strains circulating in Europe. PLoS One 9(2):e89635. doi:10.1371/journal.pone.0089635 PubMed CentralView ArticlePubMedGoogle Scholar
- Gulig PA, Curtiss R 3rd (1987) Plasmid-associated virulence of Salmonella Typhimurium. Infect Immun 55(12):2891–2901PubMed CentralPubMedGoogle Scholar
- Haneda T, Ishii Y, Shimizu H, Ohshima K, Iida N, Danbara H et al (2012) Salmonella type III effector SpvC, a phosphothreonine lyase, contributes to reduction in inflammatory response during intestinal phase of infection. Cell Microbiol 14(4):485–499. doi:10.1111/J.1462-5822.2011.01733.X View ArticlePubMedGoogle Scholar
- Heithoff DM, Conner CP, Hanna PC, Julio SM, Hentschel U, Mahan MJ (1997) Bacterial infection as assessed by in vivo gene expression. Proc Natl Acad Sci USA 94(3):934–939. doi:10.1073/Pnas.94.3.934 PubMed CentralView ArticlePubMedGoogle Scholar
- Herrero-Fresno A, Rodicio R, Montero I, Garcia P, Rodicio MR (2015) Transposition and homologous recombination drive evolution of pUO-StVR2, a multidrug resistance derivative of pSLT, the virulence plasmid specific of Salmonella enterica serovar Typhimurium. Infect Gen Evol J Mol Epidem Evol Genet Infect Dis 29:99–102. doi:10.1016/j.meegid.2014.11.010 View ArticleGoogle Scholar
- Lesnick ML, Reiner NE, Fierer J, Guiney DG (2001) The Salmonella spvB virulence gene encodes an enzyme that ADP-ribosylates actin and destabilizes the cytoskeleton of eukaryotic cells. Mol Microbiol 39(6):1464–1470. doi:10.1046/J.1365-2958.2001.02360.X View ArticlePubMedGoogle Scholar
- Libby SJ, Adams LG, Ficht TA, Allen C, Whitford HA, Buchmeier NA et al (1997) The spv genes on the Salmonella Dublin virulence plasmid are required for severe enteritis and systemic infection in the natural host. Infect Immun 65(5):1786–1792PubMed CentralPubMedGoogle Scholar
- Liu WQ, Feng Y, Wang Y, Zou QH, Chen F, Guo JT et al (2009) Salmonella Paratyphi C: Genetic Divergence from Salmonella Choleraesuis and Pathogenic Convergence with Salmonella Typhi. Plos One 4(2):ARTN e4510. doi:10.1371/journal.pone.0004510 View ArticleGoogle Scholar
- Matsui H, Isshiki Y, Eguchi M, Ogawa Y, Shimoji Y (2015) Evaluation of the live vaccine efficacy of virulence plasmid-cured, and phoP- or aroA-deficient Salmonella enterica serovar Typhimurium in mice. J Vet Med Sci 77(2):181–186. doi:10.1292/jvms.14-0013 PubMed CentralView ArticlePubMedGoogle Scholar
- Mazurkiewicz P, Thomas J, Thompson JA, Liu M, Arbibe L, Sansonetti P et al (2008) SpvC is a Salmonella effector with phosphothreonine lyase activity on host mitogen-activated protein kinases. Mol Microbiol 67(6):1371–1383. doi:10.1111/J.1365-2958.2008.06134.X PubMed CentralView ArticlePubMedGoogle Scholar
- Nakamura M, Sato S, Ohya T, Suzuki S, Ikeda S (1985) Possible relationship of a 36-megadalton Salmonella Enteritidis plasmid to virulence in mice. Infect Immun 47(3):831–833PubMed CentralPubMedGoogle Scholar
- Novick RP (1987) Plasmid incompatibility. Microbiol Rev 51(4):381–395PubMed CentralPubMedGoogle Scholar
- Ou JT, Baron LS, Dai XY, Life CA (1990) The virulence plasmids of Salmonella Serovars Typhimurium, Choleraesuis, Dublin, and Enteritidis, and the cryptic plasmids of Salmonella serovars Copenhagen and Sendai belong to the same incompatibility group, but not those of Salmonella Serovars Durban, Gallinarum, Give, Infantis and Pullorum. Microb Pathogenesis 8(2):101–107. doi:10.1016/0882-4010(90)90074-Z View ArticleGoogle Scholar
- Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring HarborGoogle Scholar
- Tezcan-Merdol D, Nyman T, Lindberg U, Haag F, Koch-Nolte F, Rhen M (2001) Actin is ADP-ribosylated by the Salmonella enterica virulence-associated protein SpvB. Mol Microbiol 39(3):606–619. doi:10.1046/J.1365-2958.2001.02258.X View ArticlePubMedGoogle Scholar
- Tinge SA, Curtiss R 3rd (1990) Conservation of Salmonella Typhimurium virulence plasmid maintenance regions among Salmonella serovars as a basis for plasmid curing. Infect Immun 58(9):3084–3092PubMed CentralPubMedGoogle Scholar
- Trevors JT (1986) Plasmid curing in bacteria. FEMS Microbiol Lett 32(3–4):149–157View ArticleGoogle Scholar
- Uzzau S, Gulig PA, Paglietti B, Leori G, Stocker BA, Rubino S (2000) Role of the Salmonella abortusovis virulence plasmid in the infection of BALB/c mice. FEMS Microbiol Lett 188(1):15–18View ArticlePubMedGoogle Scholar